Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 100 clinical trials
Alopecia Prevention Scalp Cooling in Chinese Breast Cancer Patients

Prevention System to prevent chemotherapy-induced alopecia. This project seeks to demonstrate that the Orbis Paxman Hair Loss Prevention System is safe and effective in reducing chemotherapy-induced

breast cancer staging
trastuzumab
carboplatin
adjuvant chemotherapy
taxane
  • 0 views
  • 14 May, 2022
  • 1 location
A Study to Evaluate the Efficacy and Safety of AD-208

The purpose of this study is to evaluate the efficacy and safety of AD-208.

  • 0 views
  • 23 Nov, 2021
  • 1 location
COOLCAP: Pilot Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors

This study is being done to see if the Paxman scalp cooling device can prevent hair loss in pediatric patients receiving chemotherapy for non-cancerous conditions or solid tumors. Primary

scalp cooling
antibiotics
cold
carboplatin
paclitaxel
  • 0 views
  • 24 Oct, 2022
  • 1 location
Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029

dose in healthy subjects and multiple ascending dose administration in subjects with androgenetic alopecia(AGA) or acne

androgenic alopecia
Accepts healthy volunteers
covid-19
treatment regimen
body mass index
  • 0 views
  • 12 Jul, 2022
  • 2 locations
Improving Disease Severity

. Phototherapy has shown some efficacy for other diseases, such as alopecia areata (AA) and polymorphous light eruption (PMLE). However, phototherapy is not always an accessible treatment option for patients due

areata alopecia
phototherapy
  • 0 views
  • 07 Oct, 2022
  • 1 location
PBMT for the Management of CIA ( HAIRLASER )

-induced alopecia (CIA) occurs in about 65% of the patients. Hair loss due to CT is reversible, but hair regrowth requires several months to a year after CT. Currently, the only available preventive

breast adenocarcinoma
cancer
breast cancer
treatment regimen
taxane
  • 0 views
  • 08 Apr, 2022
  • 1 location
Cooling Cap Trial to Prevent Permanent Chemotherapy-induced Alopecia in Breast Cancer Patients

This study aims to examine whether the PSCS2 is effective in reducing chemotherapy-induced alopecia in woman with breast cancer undergoing neoadjuvant or adjuvant chemotherapy. Female adults who

adjuvant chemotherapy
taxane
adriamycin
  • 0 views
  • 20 Aug, 2021
  • 1 location
Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia

An open label, pilot study involving the use of low dose oral minoxidil to treat permanent chemotherapy-induced alopecia.

  • 63 views
  • 14 Jun, 2022
  • 1 location
Tofacitinib for Immune Skin Conditions in Down Syndrome

People with Down syndrome (DS) display widespread immune dysregulation, including several immune skin conditions. This study hypothesizes that pharmacological inhibition of the increased interferon (IFN) signaling seen in DS is safe and could improve associated skin conditions. The study evaluates the safety and efficacy treatment with Tofacitinib, an FDA-approved drug …

mediators
vitiligo
skin disorder
hidradenitis
dermatitis
  • 88 views
  • 04 Oct, 2022
  • 1 location
Effect of Helmet Type, Home-use Low-level Light Therapy Device for Chemotherapy-induced Alopecia

-induced alopecia (CIA) affects up to 65% of the patients. This condition is reversible. Nevertheless, it takes several months after CT for visible hair regrowth. Different characteristics of the new hair

taxane
paclitaxel
docetaxel
  • 0 views
  • 04 Oct, 2022
  • 1 location